Correction: Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion

Eva Juengel; Geraldine Krueger; Jochen Rutz; Karen Nelson; Isabella Werner; Borna Relja; Barbara Seliger; Beate Fisslthaler; Ingrid Fleming; Igor Tsaur; Axel Haferkamp; Roman A. Blaheta

doi:10.18632/oncotarget.14438

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion

Eva Juengel _, Geraldine Krueger, Jochen Rutz, Karen Nelson, Isabella Werner, Borna Relja, Barbara Seliger, Beate Fisslthaler, Ingrid Fleming, Igor Tsaur, Axel Haferkamp and Roman A. Blaheta

PDF | How to cite

Oncotarget. 2017; 8:1953-1954. https://doi.org/10.18632/oncotarget.14438

Metrics: PDF 3189 views | ?

Present: Due to an error in the production process, figures 5 and 6 were switched. Each figure legend is correct, but is associated with the wrong figure.

Corrected: The proper figure legends are provided below. The publisher sincerely apologizes for this oversight.

Original article: Oncotarget. 2016; 7(15):20410-24. DOI: 10.18632/oncotarget.7804.

Figure 5: Endothelial surface expression of adhesion receptors on HUVEC after TNF-alpha [500 U/ml] stimulation and/or co-cultivation with Caki-1 cells under flow conditions. Expression of ICAM-1, VCAM-1 and E-selectin after 24h TNF- alpha [500 U/ml] stimulation. MFI = mean relative fluorescence intensity. *indicates significant difference to untreated controls. #indicates significant difference to TNF-alpha/histamine stimulated HUVEC. n=6.

Figure 6: Endothelial surface expression of adhesion receptors on HMEC-1 and HC-6014 cells after TNF-alpha [500 U/ml] stimulation and/or co-cultivation with Caki-1 cells. Expression of ICAM-1, VCAM-1 and E-selectin after 24h TNF-alpha [500 U/ml] stimulation. MFI = mean relative fluorescence intensity. *indicates significant difference to untreated controls. #indicates significant difference to TNF-alpha stimulated HUVEC. n=5.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14438

Publication Alerts

Corrections:

Correction: Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion